Nimodipine improves outcome when given after complete cerebral ischemia in primates

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Complete cerebral ischemia can lead to severe neurological deficits.
• Effective treatments to mitigate ischemic brain injury are crucial.

Purpose of the Study:

• To evaluate the efficacy of nimodipine in improving neurological outcomes after complete cerebral ischemia in primates.

Main Methods:

• Twenty-seven pigtailed monkeys underwent 17 minutes of complete cerebral ischemia.
• The treatment group received nimodipine post-ischemia; the control group did not.
• Neurological function and histopathology were assessed at 96 hours.

Main Results:

• Nimodipine-treated monkeys showed significantly better neurological outcomes and lower histopathology scores.
• Eight of 11 treated animals had normal consciousness; only two of 10 controls did.
• Histopathology revealed variable ischemic changes, with no significant white matter damage.

Conclusions:

• Nimodipine administration post-cerebral ischemia improves neurological outcome in primates.
• Controlled clinical trials in cardiac arrest patients are recommended.